Published in J Neural Transm (Vienna) on April 28, 2006
Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics (2007) 1.55
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol (2008) 1.34
In vivo mapping of the human locus coeruleus. Neuroimage (2009) 1.21
Glutathione metabolism and Parkinson's disease. Free Radic Biol Med (2013) 1.20
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Prog Neurobiol (2015) 0.97
Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage (2015) 0.88
Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation. J Neural Transm (Vienna) (2011) 0.87
Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin. Neural Regen Res (2014) 0.79
Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS One (2014) 0.78
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Biomolecules (2015) 0.77
Frontopolar cortex and decision-making efficiency: comparing brain activity of experts with different professional background during an exploration-exploitation task. Front Hum Neurosci (2014) 0.77
Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging. Neurobiol Aging (2015) 0.77
A reappraisal of Fe(III) adsorption by melanin. J Neural Transm (Vienna) (2014) 0.77
Parkinson's Disease: The Mitochondria-Iron Link. Parkinsons Dis (2016) 0.76
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta (1996) 6.15
Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov (2004) 5.82
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol (1999) 3.63
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol (2003) 3.57
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (1988) 3.12
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron (2003) 2.80
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology (2003) 2.04
Epidemiology of Parkinson's disease. Neurol Clin (1996) 1.86
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol (1991) 1.69
Disease-specific patterns of locus coeruleus cell loss. Ann Neurol (1992) 1.64
Chronic manganese intoxication. Arch Neurol (1974) 1.61
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A (2004) 1.59
Brain iron pathways and their relevance to Parkinson's disease. J Neurochem (2001) 1.55
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci (2003) 1.51
A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem (1995) 1.40
Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol (1989) 1.37
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem (2001) 1.33
Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res (1975) 1.30
Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science (1986) 1.26
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett (2002) 1.22
The neuromelanin of human substantia nigra: physiological and pathogenic aspects. Pigment Cell Res (2004) 1.12
Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase. J Comp Neurol (1979) 1.10
Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem (1994) 1.10
Interaction of human substantia nigra neuromelanin with lipids and peptides. J Neurochem (2000) 1.09
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem J (2003) 1.08
Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain (1995) 1.05
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience (1996) 1.05
A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord. Brain Res (1977) 1.02
The neuromelanin of human substantia nigra and its interaction with metals. J Neural Transm (Vienna) (2002) 1.00
Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol (2004) 0.99
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. Biochim Biophys Acta (1995) 0.98
Manganese intoxication. Arch Neurol (2000) 0.97
On the origin and significance of neuromelanin. Arch Pathol Lab Med (1979) 0.96
Studies on neuromelanin. II. Melanin in the brainstems of infants and children. Neurology (1968) 0.95
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin. Neurosci Lett (1988) 0.95
Total and paramagnetic metals in human substantia nigra and its neuromelanin. J Neural Transm Park Dis Dement Sect (1993) 0.91
MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies. J Neurol (2000) 0.90
Noradrenergic mechanisms in age-related cognitive decline. J Neural Transm Suppl (1987) 0.81
MELANOGENESIS AND EXTRAPYRAMIDAL DISEASES. Fed Proc (1964) 0.80
An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators. Curr Med Chem (2003) 0.79
The motor circuit of the human basal ganglia reconsidered. J Neural Transm Suppl (2000) 0.75
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet (2000) 3.12
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol (2002) 2.94
Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology (1991) 2.53
Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology (2012) 2.31
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem (1991) 2.12
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem (2000) 1.88
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology (2007) 1.61
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study. Case report. J Neurosurg (2000) 1.60
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J (1992) 1.58
Brain iron pathways and their relevance to Parkinson's disease. J Neurochem (2001) 1.55
T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology (1999) 1.52
Calcified left atrial myxoma simulating mitral insufficiency. Hemodynamic and phonocardiographic effects of tumor movement. Circulation (1967) 1.49
Systemic and myocardial hemodynamic responses to relatively small concentrations of carboxyhemoglobin (COHB). Arch Environ Health (1969) 1.44
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol (1994) 1.43
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem (1993) 1.43
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des (2007) 1.41
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet (2005) 1.40
Myocardial and systemic responses to carboxyhemoglobin. Ann N Y Acad Sci (1970) 1.40
The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica (1992) 1.39
Simultaneous determination of arsenic, antimony, cadmium, chromium, copper, and selenium in environmental material by radiochemical neutron activation analysis. Anal Chem (1978) 1.38
Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis. AIDS (1995) 1.37
Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol (1998) 1.37
Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg (1975) 1.36
Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ (1990) 1.33
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem (2001) 1.33
Determination of trace elements and evaluation of their enrichment factors in Himalayan lichens. Environ Pollut (2002) 1.29
Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood (1999) 1.27
Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci U S A (2004) 1.24
The properties of a mammary gland cancer stem cell. Proc Natl Acad Sci U S A (2007) 1.24
Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. Free Radic Biol Med (1997) 1.23
Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol (1985) 1.20
Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res (2000) 1.20
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS (1998) 1.19
Quantitative analysis of hepatitis B virus DNA by real-lime amplification. Eur J Clin Microbiol Infect Dis (2002) 1.18
Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. Protein Expr Purif (2000) 1.13
Primary angiitis of the central nervous system: serial MRI of brain and spinal cord. Neuroradiology (2001) 1.12
Comparison between the accumulation capacity of four lichen species transplanted to a urban site. Environ Pollut (2007) 1.12
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Neurodegener Dis (2008) 1.10
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer (1999) 1.10
Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost (1992) 1.08
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology (2006) 1.07
An immunoassay for specific amplified HCV sequences. J Virol Methods (1991) 1.06
Purification and characterization of a thermostable carboxypeptidase from the extreme thermophilic archaebacterium Sulfolobus solfataricus. Eur J Biochem (1992) 1.06
The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest (1971) 1.05
Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery (2000) 1.05
Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood (1998) 1.04
Cellular retention, toxicity and carcinogenic potential of seafood arsenic. I. Lack of cytotoxicity and transforming activity of arsenobetaine in the BALB/3T3 cell line. Carcinogenesis (1991) 1.03
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol (1988) 1.01
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? Arch Neurol (1982) 1.01
Artistic productivity and creative thinking in Parkinson's disease. Eur J Neurol (2011) 1.00
Changes in the cardiac glutathione status after ischemia and reperfusion. Experientia (1985) 1.00
Systemic hemodynamic and myocardial metabolic effects of isoproterenol and angiotensin after open-heart surgery. Circulation (1970) 1.00
The neuromelanin of human substantia nigra and its interaction with metals. J Neural Transm (Vienna) (2002) 1.00
Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases. Virchows Arch A Pathol Anat Histopathol (1993) 0.98
Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol (1994) 0.98
The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J Neural Transm Park Dis Dement Sect (1994) 0.98
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. Biochim Biophys Acta (1995) 0.98
A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control (1999) 0.97
Carboxyhemoglobin: Hemodynamic and Respiratory Responses to Small Concentrations. Science (1965) 0.97
The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol Sci (2001) 0.97
Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction. Circulation (1972) 0.97
Trace elements determination in lichens and in the airborne particular matter for the evaluation of the atmospheric pollution in a region of northern Italy. Environ Int (2001) 0.96
Construction of plasmids carrying lacI mutations. J Mol Biol (1985) 0.96
Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells. Immunogenetics (1995) 0.96
Myocardial recovery during post-ischaemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol (1986) 0.96
Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry (2006) 0.95
Characterization of human ferritin H chain synthetized in Escherichia coli. Gene (1987) 0.95
Long-term treatment with mianserin: a clinical study with plasma levels. Adv Biochem Psychopharmacol (1982) 0.95
Near-GeV acceleration of electrons by a nonlinear plasma wave driven by a self-guided laser pulse. Phys Rev Lett (2009) 0.95
Incorporation of tritium-labelled actinomycin in a human cell line. Exp Cell Res (1966) 0.95
Bright multi-keV harmonic generation from relativistically oscillating plasma surfaces. Phys Rev Lett (2007) 0.94
Modulation by neuromelanin of the availability and reactivity of metal ions. Ann Neurol (1992) 0.94
Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner. Free Radic Biol Med (2001) 0.94
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol (1997) 0.94
Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants. Ann Oncol (2002) 0.93
Observation of synchrotron radiation from electrons accelerated in a petawatt-laser-generated plasma cavity. Phys Rev Lett (2008) 0.93
Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol. J Clin Invest (1970) 0.92
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem (2000) 0.92
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol (2007) 0.92
Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra. J Neurochem (1995) 0.92
Structural features responsible for kinetic thermal stability of a carboxypeptidase from the archaebacterium Sulfolobus solfataricus. Biochem J (1993) 0.92
Polyphosphoinositide metabolism is rapidly stimulated by activation of a temperature-sensitive mutant of Rous sarcoma virus in rat fibroblasts. Oncogene (1987) 0.92
Therapeutic surgical division of the human conduction system. JAMA (1967) 0.92
Construction of a ferroxidase center in human ferritin L-chain. J Biol Chem (1994) 0.91
Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat Disord (2006) 0.91
Serodiagnosis of Helicobacter pylori-associated gastritis with a monoclonal antibody competitive enzyme-linked immunosorbent assay. Scand J Gastroenterol (1992) 0.91
Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels. Transfusion (1995) 0.90
Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop Relat Res (1989) 0.90
Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates. J Clin Microbiol (1995) 0.90
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90
Influence of neuromelanin on oxidative pathways within the human substantia nigra. Neurotoxicol Teratol (2002) 0.90